COMPLEX ASSESSMENT OF COMPENSATION IN DIABETES MELLITUS TYPE 1 ACCORDING TO THE RESULTS OF CONTINUOUS GLUCOSE MONITORING
https://doi.org/10.51523/2708-6011.2016-13-3-26
Abstract
Objective: to give complex assessment of compensation in diabetes mellitus type 1 (DM 1) using the continuous glucose monitoring system. Material and methods. The study included 162 patients with DM 1 who were examined using the complex of methods: questionnaire survey, clinical and anamnestic analysis, laboratory investigation of glycohemoglobin level, and continuous glucose monitoring using a CGMS system. Results. The data analysis has showed that only 23% examined patients have adequate control of DM 1. The quality of DM 1 control did not depend on age, DM 1 duration and body mass index (BMI). The highest glycemia variability depended on the total daily dose of injected short action insulin. We have found a high risk for development of hypoglycemia episodes independently of DM 1 quality control. Conclusion. In order to prescribe correct treatment for patients with DM 1, besides the main target criteria of compensation, it is very important to determine the hypoglycemia and hyperglycemia risk indices as well as clinical hypoglycemic reactions for the assessment of DM 1 compensation.
About the Authors
E. S. Makhlina
Gomel State Medical University
Belarus
Belarus
M. P. Kapliyeva
Gomel State Medical University
Belarus
Belarus
Ya. L. Navmenova
Republican Scientific Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
I. G. Savasteyeva
Republican Scientific Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
References
1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. - 1993. - Vol. 329. - Р. 977-986.
2. The Diabetes Control and Complications Trial Research Group. Sustained effect on intensive treatment of type 1 diabetes Mellitus on development and progression of diabetic nephropathy // JAMA. - 2003. - Vol. 290. - Р. 2159-2167.
3. The Diabetes Control and Complications Trial Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes // N. Engl. J. Med. - 2005. - Vol. 354. - Р. 2643-2653.
4. DCCT/EDIC Research Group. Neuropathy among the diabetes control and complications trial cohort 8years after trial completion / C. L. Martin [et al.] // Diabetes Care. - 2006. - Vol. 29. - Р. 340-344.
5. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial / N. Р. White [et al.] // Arch.Ophthalmol. - 2008. - Vol. 126. - Р. 1707-1715.
6. ADA Standards of Medical Care in Diabetes-2010 // Diabetes care. - 2010. - Vol. 33. - Р. 11-61.
7. Возможно ли поддержание строгого контроля углеводного обмена у больных сахарным диабетом на протяжении длительного времени? / М. И. Балаболкин [и др.] // Леч. врач. - 2008. - № 3. - С. 6-10.
8. Вельков, В. В. Память о сахаре в крови: гликозилированный гемоглобин. Новые возможности для диагностики, терапии и оценки рисков / В. В. Вельков. - Пущино: ОНТИ ПНЦ РАН, 2006. - 42 с.
9. Роль конечных продуктов гликирования в патогенезе осложнений сахарного диабета / N. Ahmed [и др.] // Рус. мед. журн. - 2009. - № 9. - С. 642-650.
10. The DCCT/EDIC Study Research Group. Long-Term Effect of Diabetes and Its Treatment on Cognitive Function // N. Engl. J. Med. - 2007. - Vol. 356, № 18. - Р. 1842-1852.
11. Streja, D. Can Continuous Glucose Monitoring Provide Objective Documentation of Hypoglycemia Unawareness? / D. Streja // Endocr. Pract. - 2005. - Vol. 11. - Р. 83-90.
12. Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and Beta-Cell Dysfunction? / J. Evans [аt al.] // Diabetes. - 2003. - Vol. 52, № 1. - Р. 1-8.
13. Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes. The Framingham Offspring Study / J. Meigs [аt al.] // Diabetes Care. - 2007. - Vol. 30. - Р. 2529-2535.
14. No Relevant Relationship between Glucose Variability and Oxidative Stress in Well-Regulated Type 2 Diabetes Patients / S. E. Siegelaar [аt al.] // J. Diabetes Sci. Technol. - 2011. - Vol. 5, № 1. - Р. 86-92.
15. Baynes, J. W. The role of oxidative stress in diabetic compli-cations / J. W. Baynes, S. R. Thorpe // Diabetes. - 1999. - Vol. 48. - Р. 1-9.
16. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications / М. Brownlee // Nature. - 2001. - Vol. 414. - Р. 813-820.
17. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use / Т. М. Gross [et al.] // Diabetes Technol. Ther. - 2000. - Vol. 2, № 1. - Р. 49-56.
18. Symmetrization of the blood glucose measurement scale and its applications / B. Р. Kovatchev [et al.] // Diabetes Care. - 1997. - Vol. 20, № 11. - Р. 1655-1658.
19. Diabetes Control and Complications Trial (DCCT) Research Group. The absence of a glycemic threshold for the development of longterm complications: the perspective of the Diabetes Control and Complications Trial // Diabetes. - 1996. - Vol. 45, № 10. - Р. 1289-1298.
Review
For citations:
Makhlina E.S., Kapliyeva M.P., Navmenova Ya.L., Savasteyeva I.G. COMPLEX ASSESSMENT OF COMPENSATION IN DIABETES MELLITUS TYPE 1 ACCORDING TO THE RESULTS OF CONTINUOUS GLUCOSE MONITORING. Health and Ecology Issues. 2016;(3):118-122. (In Russ.) https://doi.org/10.51523/2708-6011.2016-13-3-26
Views: 301
Email this article 